ArticlePloS one2025
FLUid management and InDividualized resuscitation in Sepsis (FLUIDS)-A Study protocol for a single-centre, open-label, randomized clinical trial.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07009665 (Fluid Management and Individualized Resuscitation in Sepsis), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Fluid Management and Individualized Resuscitation in Sepsis
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly septic shock results from complex hemodynamic disturbances, including vasodilation, capillary leakage, and hypovolemia, requiring timely resuscitation to prevent organ failure. Initial fluid administration in the emergency department (ED) varies widely, influenced by clinician experience, patient comorbidities, and infection source. Fluid therapy is frequently not tailored to individual patient responsiveness and tolerance, highlighting the importance of personalized resuscitation strategies.
objectiveThis study evaluates the effectiveness of a personalized hemodynamic resuscitation strategy during the initial management of sepsis in the ED, using continuous non-invasive stroke volume index (SVI) measurements to guide intravenous (IV) fluid therapy and early vasopressor initiation.
methodThis single-centre, open-label, randomized clinical trial at the Emergency Department of the University Medical Centre Groningen, the Netherlands, will enroll 188 adults with suspected sepsis requiring hemodynamic resuscitation, defined by a mean arterial pressure (MAP) <70 mmHg, systolic blood pressure (SBP) <90 mmHg, shock index >0.9, or lactate concentration >4.0 mmol/L. Deferred consent will be obtained within 30 days of ED presentation. Patients will be randomized to the intervention group, in which fluids and vasopressors will be guided by changes in SVI (ΔSVI) after IV fluid administration, or to the control group, where fluids and vasopressors will be administered at the discretion of the treating physician during the initial 3-hour resuscitation phase. The primary endpoint is the volume of IV fluids administered within the first three hours after enrollment. Secondary endpoints include cumulative fluid balance, timing and dose of vasopressors, incidence of organ failure, hospital length of stay, mortality and fluid-related adverse events, including venous congestion assessed by point-of-care ultrasound. EXPECTED
resultsWe anticipate that SVI-guided resuscitation will reduce IV fluid volume compared to standard care. This personalized approach, tailoring fluid and vasopressor administration to the individual's hemodynamic needs, has the potential to improve outcomes for patients with sepsis.
trial registrationClinicalTrials.gov NCT07009665.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.